Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Di Vizio, Dolores ^a,b   Demichelis, Francesca ^c   Simonetti, Sara ^a   Pettinato, Guido ^a   Terracciano, Luigi ^d   Tornillo, Luigi ^d   Freeman, Michael R ^b,e   Insabato, Luigi ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF BASEL   (Switzerland)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; JAB 1 PROTEIN; KI 67 ANTIGEN; S PHASE KINASE ASSOCIATED PROTEIN 2; COPS5 PROTEIN, HUMAN; PEPTIDE HYDROLASE; S PHASE KINASE ASSOCIATED PROTEIN; SIGNAL PEPTIDE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RELAPSE; CANCER SIZE; CANCER SURVIVAL; CELL CYCLE REGULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MITOSIS RATE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; TISSUE MICROARRAY; TUMOR NECROSIS; BIOSYNTHESIS; METABOLISM; MIDDLE AGED; PATHOLOGY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; RISK FACTORS; S-PHASE KINASE-ASSOCIATED PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 44449129635     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-134     Document Type: Article

References (35)

1. Fletcher CD Berman JJ Corless C Gorstein F Lasota J Longley BJ Miettinen M O'Leary TJ Remotti H Rubin BP Shmookler B Sobin LH Weiss SW Diagnosis of gastrointestinal stromal tumors: A consensus approach Int J Surg Pathol 2002, 10(2):81-89 10.1177/106689690201000201 12075401
2. Miettinen M Lasota J Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis Arch Pathol Lab Med 2006, 130(10):1466-1478 17090188
3. Tornillo L Duchini G Carafa V Lugli A Dirnhofer S Di Vizio D Boscaino A Russo R Tapia C Schneider-Stock R Sauter G Insabato L Terracciano LM Patterns of gene amplification in gastrointestinal stromal tumors (GIST) Lab Invest 2005, 85(7):921-931 10.1038/labinvest.3700284 15864317
4. Sun H Lesche R Li DM Liliental J Zhang H Gao J Gavrilova N Mueller B Liu X Wu H PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway Proc Natl Acad Sci U S A 1999, 96(11):6199-6204 26859 10339565 10.1073/pnas.96.11.6199
5. Di Vizio D Cito L Boccia A Chieffi P Insabato L Pettinato G Motti ML Schepis F D'Amico W Fabiani F Tavernise B Venuta S Fusco A Viglietto G Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors Oncogene 2005, 24(11):1882-1894 10.1038/sj.onc.1208368 15674339
6. Ricci R Maggiano N Castri F Rinelli A Murazio M Pacelli F Potenza AE Vecchio FM Larocca LM Role of PTEN in gastrointestinal stromal tumor progression Arch Pathol Lab Med 2004, 128(4):421-425 15043466
7. Miettinen M Lasota J Gastrointestinal stromal tumors: Pathology and prognosis at different sites Semin Diagn Pathol 2006, 23(2):70-83 10.1053/j.semdp.2006.09.001 17193820
8. Wong NA Young R Malcomson RD Nayar AG Jamieson LA Save VE Carey FA Brewster DH Han C Al-Nafussi A Prognostic indicators for gastrointestinal stromal tumours: A clinicopathological and immunohistochemical study of 108 resected cases of the stomach Histopathology 2003, 43(2):118-126 10.1046/j.1365-2559.2003.01665.x 12877726
9. Baghdassarian N Ffrench M Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies Hematol Cell Ther 1996, 38(4):313-323 10.1007/ s00282-996-0313-4 8891723
10. Hershko DD Shapira M Prognostic role of p27Kip1 deregulation in colorectal cancer Cancer 2006, 107(4):668-675 10.1002/cncr.22073 16826582
11. Goto Y Kawauchi S Ihara K Ikemoto K Ohi R Kawai S Sasaki K The prognosis in spindle-cell sarcoma depends on the expression of cyclin-dependent kinase inhibitor p27(Kip1) and cyclin E Cancer Sci 2003, 94(5):412-417 10.1111/j.1349-7006.2003.tb01456.x 12824885
12. Salerno G Di Vizio D Staibano S Mottola G Quaremba G Mascolo M Galli V De Rosa G Insabato L Prognostic value of p27Kip1 expression in Basaloid Squamous Cell Carcinoma of the larynx BMC Cancer 2006, 6:146 1559634 16740156 10.1186/1471-2407-6-146
13. Schneider-Stock R Boltze C Lasota J Peters B Corless CL Ruemmele P Terracciano L Pross M Insabato L Di Vizio D Iesalnieks I Dirnhofer S Hartmann A Heinrich M Miettinen M Roessner A Tornillo L Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study Clin Cancer Res 2005, 11(2 Pt 1):638-645 15701851
14. Ricci R Arena V Castri F Martini M Maggiano N Murazio M Pacelli F Potenza AE Vecchio FM Larocca LM Role of p16/INK4a in gastrointestinal stromal tumor progression Am J Clin Pathol 2004, 122(1):35-43 10.1309/ MJ4X-N2M5-7HNC-8X5H 15272528
15. Nakamura N Yamamoto H Yao T Oda Y Nishiyama K Imamura M Yamada T Nawata H Tsuneyoshi M Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade Hum Pathol 2005, 36(7):828-837 10.1016/ j.humpath.2005.03.012 16084954
16. Sabah M Cummins R Leader M Kay E Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: Markers with potential prognostic implications Hum Pathol 2006, 37(6):648-655 10.1016/ j.humpath.2006.01.023 16733203
17. Pruneri G Mazzarol G Fabris S Del Curto B Bertolini F Neri A Viale G Cyclin D3 immunoreactivity in gastrointestinal stromal tumors is independent of cyclin D3 gene amplification and is associated with nuclear p27 accumulation Mod Pathol 2003, 16(9):886-892 10.1097/ 01.MP.0000085026.38856.B9 13679452
18. Shirin H Kravtsov V Shahmurov M Shabat VS Krinshpon I Alin A Avinoach I Avni Y The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST Digestion 2007, 75(1):4-9 10.1159/ 000101457 17406118
19. Tomoda K Kubota Y Arata Y Mori S Maeda M Tanaka T Yoshida M Yoneda-Kato N Kato JY The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex J Biol Chem 2002, 277(3):2302-2310 10.1074/jbc.M104431200 11704659
20. Goto A Niki T Moriyama S Funata N Moriyama H Nishimura Y Tsuchida R Kato JY Fukayama M Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma Pathol Int 2004, 54(9):675-681 10.1111/j.1440-1827.2004.01679.x 15363035
21. Pagano M Tam SW Theodoras AM Beer-Romero P Del Sal G Chau V Yew PR Draetta GF Rolfe M Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 Science 1995, 269(5224):682-685 10.1126/science.7624798 7624798
22. Hulit J Lee RJ Li Z Wang C Katiyar S Yang J Quong AA Wu K Albanese C Russell R Di Vizio D Koff A Thummala S Zhang H Harrell J Sun H Muller WJ Inghirami G Lisanti MP Pestell RG p27Kip1 Repression of ErbB2-Induced Mammary Tumor Growth in Transgenic Mice Involves Skp2 and Wnt/ {beta}-Catenin Signaling Cancer Res 2006, 66(17):8529-8541 10.1158/ 0008-5472.CAN-06-0149 16951165
23. Oliveira AM Okuno SH Nascimento AG Lloyd RV Skp2 protein expression in soft tissue sarcomas J Clin Oncol 2003, 21(4):722-727 10.1200/ JCO.2003.05.112 12586812
24. Kouvaraki MA Rassidakis GZ Tian L Kumar R Kittas C Claret FX Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1) Cancer Res 2003, 63(11):2977-2981 12782606
25. Kouvaraki MA Korapati AL Rassidakis GZ Tian L Zhang Q Chiao P Ho L Evans DB Claret FX Potential role of Jun activation domain-binding protein 1 as a negative regulator of p27kip1 in pancreatic adenocarcinoma Cancer Res 2006, 66(17):88581-8589 1780177 16951171 10.1158/ 0008-5472.CAN-06-0975
26. Ozguc H Yilmazlar T Yerci O Soylu R Tumay V Filiz G Zorluoglu A Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential J Gastrointest Surg 2005, 9(3):418-429 10.1016/j.gassur.2004.07.003 15749606
27. Daum O Grossmann P Vanecek T Sima R Mukensnabl P Michal M Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: Molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors Ann Diagn Pathol 2007, 11(1):27-33 10.1016/j.anndiagpath.2006.10.002 17240304
28. Bertin M Angriman I Scarpa M Mencarelli R Ranzato R Ruffolo C Polese L Iacobone M D'Amico DF Prognosis of gastrointestinal stromal tumors Hepatogastroenterology 2007, 54(73):124-128 17419245
29. Penin RM Fernandez-Figueras MT Puig L Rex J Ferrandiz C Ariza A Over-expression of p45(SKP2) in Kaposi's sarcoma correlates with higher tumor stage and extracutaneous involvement but is not directly related to p27(KIP1) down-regulation Mod Pathol 2002, 15(11):1227-1235 10.1097/ 01.MP.0000036589.99516.D6 12429803
30. Li JQ Wu F Masaki T Kubo A Fujita J Dixon DA Beauchamp RD Ishida T Kuriyama S Imaida K Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors Int J Oncol 2004, 25(1):87-95 15201993
31. Gelen T Elpek GO Aksoy NH Ogus M Keles N p27 Labeling index and proliferation in gastrointestinal stromal tumors: Correlations with clinicopathologic factors and recurrence Jpn J Clin Oncol 2003, 33(7):346-352 10.1093/jjco/hyg071 12949061
32. Nemoto Y Mikami T Hana K Kikuchi S Kobayashi N Watanabe M Okayasu I Correlation of enhanced cell turnover with prognosis of gastrointestinal stromal tumors of the stomach: Relevance of cellularity and p27kip1 Pathol Int 2006, 56(12):724-731 10.1111/j.1440-1827.2006.02038.x 17096729
33. Grimmler M Wang Y Mund T Cilensek Z Keidel EM Waddell MB Jakel H Kullmann M Kriwacki RW Hengst L Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases Cell 2007, 128(2):269-280 10.1016/j.cell.2006.11.047 17254966
34. Carrano AC Eytan E Hershko A Pagano M SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 Nat Cell Biol 1999, 1(4):193-199 10.1038/12013 10559916
35. Latres E Chiarle R Schulman BA Pavletich NP Pellicer A Inghirami G Pagano M Role of the F-box protein Skp2 in lymphomagenesis Proc Natl Acad Sci U S A 2001, 98(5):2515-2520 30169 11226270 10.1073/ pnas.041475098